Re: Good price action
Sorry, Wilderman. Can't give you a sales pitch on the approval pathway yet. Too early for that; and I'm traveling, reading all the exuberance for EXEL on my iPhone; not an easy interface to type in a noisy restaurant with drinks flying about.
But RCC is a long term prospect, 5+ years until approval in any indication for RCC, unless they get BTS. TNBC offers a shorter pathway to approval; more opportunities for BTS.
My gut tells me CALA won't last beyond a couple years before it is acquired. After they show irrefutable evidence of synergy with nivo, BMY will buy them on the cheap, around $1bil, upfront and milestones, to augment their position in RCC. Hell, it could happen later this year.